BLA
发表于 2025-3-25 04:14:56
http://reply.papertrans.cn/31/3084/308382/308382_21.png
招待
发表于 2025-3-25 11:23:37
http://reply.papertrans.cn/31/3084/308382/308382_22.png
头脑冷静
发表于 2025-3-25 15:27:12
http://reply.papertrans.cn/31/3084/308382/308382_23.png
饶舌的人
发表于 2025-3-25 16:13:24
,Einführung in die Welt des Neuromarketing,nues to be used in the head-injured patient for the control of increased intracranial pressure that is refractory to hyperventilation, ventricular drainage, osmotherapy, and barbiturates. Conversely, the adjunctive chemotherapeutic effect of selective brain tumor hyperthermia remains under intense investigation.
下垂
发表于 2025-3-25 20:56:37
http://reply.papertrans.cn/31/3084/308382/308382_25.png
SCORE
发表于 2025-3-26 02:05:10
http://reply.papertrans.cn/31/3084/308382/308382_26.png
愤怒事实
发表于 2025-3-26 08:16:37
http://reply.papertrans.cn/31/3084/308382/308382_27.png
EXALT
发表于 2025-3-26 11:27:06
Primary Cultures for Testing Neuroprotective Drugsure systems and their characteristics. Then we shall discuss various possible ways to experimentally induce and measure neuronal damage in these cultures in analogy to ischemic damage in vivo. Several examples of neuroprotective drug effects demonstrated in vitro will be reviewed.
Felicitous
发表于 2025-3-26 13:55:23
Stroke Models for Preclinical Trials of Neuroprotective Agentsmal stroke models (Graham, 1988; Molinari, 1988; Wiebers et al., 1990; Zivin and Grotta, 1990). An important issue, i.e., the quality of animal trials, however, has not been adequately addressed previously and will be the main focus of this review.
字形刻痕
发表于 2025-3-26 19:53:10
Membrane-Derived Lipid Second Messengers as Targets for Neuroprotection: Platelet-Activating Factorrg et al., 1990), and experimental allergic encephalomyelitis (Howat et al., 1989). Recent evidence shows a role for PAF in the release of excitatory amino acid neurotransmitters (Clark et al., 1991) and in long-term potentiation (Del Cerro et al., 1990).